Total planned funding: $515,679,585
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $125,151,789 |
Zambia | $89,383,028 |
Mozambique | $46,577,199 |
South Africa | $38,125,694 |
Zimbabwe | $29,468,423 |
Asia Regional Program | $24,871,345 |
Tanzania | $24,084,919 |
Vietnam | $22,020,563 |
West Africa Region | $18,148,918 |
Botswana | $13,154,283 |
Ghana | $9,732,500 |
Burundi | $9,588,040 |
Haiti | $7,848,100 |
Côte d'Ivoire | $7,153,831 |
Dominican Republic | $5,598,850 |
Democratic Republic of the Congo | $5,433,510 |
Malawi | $5,278,259 |
Kenya | $5,154,730 |
India | $4,872,700 |
South Sudan | $4,568,967 |
Rwanda | $4,281,830 |
Eswatini | $3,411,755 |
Papua New Guinea | $3,000,024 |
Namibia | $2,707,568 |
Indonesia | $2,225,000 |
Ethiopia | $1,898,800 |
Lesotho | $1,638,960 |
enumerations.Philippines | $300,000 |
Cambodia | $0 |
Caribbean Region | $0 |
Organizational Types
NGO | $515,679,585 |
Program Areas
Prevention | $146,353,363 |
Treatment | $142,857,506 |
Care | $128,534,279 |
Governance and Systems | $49,199,492 |
Testing | $48,572,651 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $124,065,528 |
HVOP: Sexual Prevention: Other Sexual Prevention | $74,998,000 |
HKID: Care: Orphans and Vulnerable Children | $60,235,201 |
HVCT: Testing: HIV Testing and Counseling | $48,572,651 |
HBHC: Care: Adult Care and Support | $47,743,296 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $44,278,329 |
PDTX: Treatment: Pediatric Treatment | $18,791,978 |
OHSS: Health Systems Strengthening | $18,746,230 |
HLAB: Laboratory Infrastructure | $16,977,472 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,964,847 |
HVSI: Strategic Information | $13,475,790 |
HVTB: Care: TB/HIV | $11,450,844 |
PDCS: Care: Pediatric Care and Support | $9,104,938 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $5,012,881 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,721,176 |
HMIN: Biomedical Prevention: Injection Safety | $295,133 |
HVMS: Management and Operations | $162,294 |
HMBL: Biomedical Prevention: Blood Safety | $82,997 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$515,679,585
View countries